- Report
- January 2024
- 200 Pages
Global
From €3933EUR$4,150USD£3,286GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €474EUR$500USD£396GBP
- Report
- November 2023
- 35 Pages
Global
From €3497EUR$3,690USD£2,922GBP
Norvir (ritonavir) is an antiretroviral drug used to treat HIV infection and AIDS. It is a protease inhibitor, which works by blocking the action of the HIV protease enzyme, preventing the virus from replicating. Norvir is used in combination with other antiretroviral drugs to treat HIV infection and AIDS. It is also used to prevent HIV infection in people who are at high risk of becoming infected.
Norvir is part of the Infectious Diseases Drugs market, which includes drugs used to treat a wide range of infectious diseases, including HIV/AIDS, malaria, tuberculosis, and other viral, bacterial, and fungal infections. These drugs are used to treat both acute and chronic infections, and can be administered orally, intravenously, or topically.
The companies in the Norvir market include AbbVie, Bristol-Myers Squibb, Gilead Sciences, Merck, and Pfizer. Show Less Read more